Yahoo Web Search

Search results

1. People also ask

   What does Jazz Pharmaceuticals do?

   • Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States.

   Jazz Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Jazz_Pharmaceuticals

   See all results for this question

   How much did Jazz Pharmaceuticals sell in 2022?

   • In 2022, Jazz Pharmaceuticals reported 1.02 billion U.S. dollars in total sales for its oxyabte drug Xyrem, while reporting some 194 million U.S. dollars in total sales for the cancer drug Defitelio in the same year. This statistic illustrates the total sales of Jazz Pharmaceuticals' top products in 2021 and 2022.

   Jazz Pharmaceuticals top products sales 2021 | Statista

   www.statista.com/statistics/1266828/jazz-pharmaceuticals-sales-by-top-products/

   See all results for this question

   Where is Jazz Pharmaceuticals headquartered?

   • Jazz Pharmaceuticals’ headquarters in Dublin. Its narcolepsy drug accounted for most of its revenue in 2021. Paulo Nunes dos Santos for The New York Times Jazz’s strategy has been criticized by the Federal Trade Commission and knocked down in court.

   A Drug Company Exploited a Safety Requirement to Make Money

   www.nytimes.com/2023/02/28/business/jazz-narcolepsy-avadel-patents.html

   See all results for this question

   What happened to Jazz Pharmaceuticals?

   • At the end of the same month, the company announced its largest acquisition to date, with the purchase of Celator Pharmaceuticals for $1.5 billion. As a result, Jazz obtained the rights to breakthrough therapy Vyxeos (liposomal daunorubicin and cytarabine) for treatment of acute myeloid leukemia.

   Jazz Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Jazz_Pharmaceuticals

   See all results for this question

2. www.jazzpharma.com › medicinesMedicines | Jazz Pharmaceuticals

   www.jazzpharma.com › medicines

   • Cached

   Learn more about Our Medicines. Jazz Pharmaceuticals has a diverse portfolio of meaningful products that address unmet medical needs in sleep and hematology/oncology.

   • Drug Safety

     Sativex is marketed in the UK by Jazz. If you are a medical...

   • Our Medicines

     Our Medicines. We operate or partner to make our medicines...

   • Medical Information US

     Healthcare professionals may request specific product...

3. en.wikipedia.org › wiki › Jazz_PharmaceuticalsJazz Pharmaceuticals - Wikipedia

   en.wikipedia.org › wiki › Jazz_Pharmaceuticals

   • Cached

   Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States.

4. Images

   • 
   • 

   View all

5. finance.yahoo.com › news › unlocking-jazzUnlocking Jazz Pharmaceuticals' Potential: A Roadmap for Growth

   finance.yahoo.com › news › unlocking-jazz

   • Cached

   Mar 14, 2024 · Jazz Pharmaceuticals PLC ( NASDAQ:JAZZ) is a fast-growing pharmaceutical company headquartered in Dublin. The company has an extensive portfolio of Food and Drug Administration-approved drugs...

6. finance.yahoo.com › quote › JAZZJazz Pharmaceuticals plc (JAZZ) Stock Price, News, Quote ...

   finance.yahoo.com › quote › JAZZ

   • Cached

   Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products for unmet medical needs in the United States, Europe, and internationally.

7. www.prnewswire.com › news-releases › jazzJazz Pharmaceuticals to Showcase Rapidly Expanding Oncology ...

   www.prnewswire.com › news-releases › jazz

   • Cached

   Apr 27, 2023 · News provided by. Jazz Pharmaceuticals plc. Apr 27, 2023, 07:30 ET. Share this article. Data from multiple studies of investigational bispecific drug zanidatamab, including pivotal Phase 2...

8. Videos

   • 

     1:04

     youtube.com

     Jazz Pharmaceuticals buys GW Pharma for $7.2 billion

     Feb 3, 2021

     2.2K Views

   • 

     6:11

     youtube.com

     JAZZ Pharmaceuticals (JAZZ) Equity Presentation by Danny Scelza

     Feb 9, 2022

     362 Views

   • 

     10:36

     investors.com

     GW Pharma Soars To Record High On Jazz's $7.2 Billion Takeover Deal

     Feb 3, 2021

     303K Views

   View all

9. www.statista.com › statistics › 1266828Jazz Pharmaceuticals top products sales 2023 | Statista

   www.statista.com › statistics › 1266828

   • Cached

   Mar 14, 2024 · Mar 14, 2024. In 2023, Jazz Pharmaceuticals reported 1.27 billion U.S. dollars in total sales for its oxyabte drug Xywav, while reporting some 184 million U.S. dollars in total sales for the...

10. www.nytimes.com › 2023/02/28 › businessA Drug Company Exploited a Safety Requirement to Make Money

    www.nytimes.com › 2023/02/28 › business

    Feb 28, 2023 · Jazz Pharmaceuticals has figured out a way to push the boundaries even further — a feat that demonstrates the lengths to which drug makers go to eke out extra profits and that two federal...